Thromboembolism
Concept
Vocabulary Service
Overview
subject area of
-
"Therapeutic range" for oral anticoagulant therapy. Academic Article
-
10 Anticoagulant therapy in venous thromboembolism Academic Article
-
2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1 Academic Article
-
4 Clinical potential of low molecular weight heparins Academic Article
-
A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation Academic Article
-
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
-
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Academic Article
-
A Comparison of Real-Time Compression Ultrasonography with Impedance Plethysmography for the Diagnosis of Deep-Vein Thrombosis in Symptomatic Outpatients Academic Article
-
A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism Academic Article
-
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism Academic Article
-
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation Academic Article
-
A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time Academic Article
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement Academic Article
-
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) Academic Article
-
A critical review of thromboembolic complications associated with central venous catheters Academic Article
-
A new noninvasive management strategy for patients with suspected pulmonary embolism Academic Article
-
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study Academic Article
-
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin Academic Article
-
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) Academic Article
-
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer Academic Article
-
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin Academic Article
-
A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy Academic Article
-
A review of the oral direct thrombin inhibitor ximelagatran Academic Article
-
A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Academic Article
-
A standard heparin nomogram for the management of heparin therapy Academic Article
-
A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism Academic Article
-
ABC of antithrombotic therapy: Venous thromboembolism: pathophysiology, clinical features, and prevention Academic Article
-
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies Academic Article
-
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Academic Article
-
Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy Academic Article
-
Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus Academic Article
-
Acquired hemophilia masked by warfarin therapy Academic Article
-
Acute Effects with Reference to Thrombogenicity and Liver Toxicity after Injection of Different Coagulation Factor Concentrates Academic Article
-
Adding aspirin to clopidogrel after TIA and ischemic stroke: Benefits do not match risks Academic Article
-
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study Academic Article
-
Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children Academic Article
-
An Update on New Anticoagulants Academic Article
-
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Academic Article
-
Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Academic Article
-
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial Academic Article
-
Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients Academic Article
-
Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Academic Article
-
Anticoagulant response after dalteparin overdose Academic Article
-
Anticoagulants in Venous Thromboembolism Academic Article
-
Anticoagulation Therapy in Children Academic Article
-
Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis Academic Article
-
Anticoagulation for prosthetic heart valves Academic Article
-
Anticoagulation for venous thromboembolism Academic Article
-
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target Academic Article
-
Anticoagulation of Pregnant Women With Mechanical Heart Valves Academic Article
-
Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada Academic Article
-
Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis Academic Article
-
Antiplatelet drugs in thromboembolism Academic Article
-
Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair Academic Article
-
Antithrombotic Agents in Coronary Artery Disease Academic Article
-
Antithrombotic Agents in Coronary Artery Disease Academic Article
-
Antithrombotic Drugs Academic Article
-
Antithrombotic Drugs Academic Article
-
Antithrombotic Therapy in Children* Academic Article
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
-
Antithrombotic and Thrombolytic Therapy: From Evidence to Application Academic Article
-
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Academic Article
-
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends Academic Article
-
Antithrombotic therapy: the expanding role of low molecular weight heparin. Academic Article
-
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review Academic Article
-
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery Academic Article
-
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement Academic Article
-
Are older patients with mechanical heart valves at increased risk? Academic Article
-
Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No Academic Article
-
Arterial thrombosis in children Academic Article
-
Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects. Academic Article
-
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants Academic Article
-
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients Academic Article
-
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery Academic Article
-
Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis Academic Article
-
Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis Academic Article
-
BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study Academic Article
-
Barriers and facilitators to optimal oral anticoagulant management: a scoping review Academic Article
-
Benefit of Selective Factor Inhibition Academic Article
-
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease Academic Article
-
Beyond heparin and warfarin: the new generation of anticoagulants Academic Article
-
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Blood tests for the diagnosis of venous and arterial thrombosis Academic Article
-
Body mass index and thromboembolism in children with hematological malignancies Academic Article
-
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study Academic Article
-
Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism Academic Article
-
Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design Academic Article
-
Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
-
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation Academic Article
-
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin Academic Article
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Surgical Therapy Academic Article
-
Canadian atrial fibrillation anticoaguiation (CAFA) study Academic Article
-
Cardioembolic Stroke Academic Article
-
Care of Patients Receiving Long-Term Anticoagulant Therapy Academic Article
-
Central Venous Line Dysfunction is an Independent Predictor of Poor Survival in Children With Cancer Academic Article
-
Cervical artery dissection: Pathology, epidemiology and management Academic Article
-
Changing Paradigms in the Management of Venous Thromboembolism Academic Article
-
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism Academic Article
-
Clinical Relevance of Bleeding Index Academic Article
-
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy Academic Article
-
Clinical Studies: Evidence for Intervention with Specific Antiplatelet Drugs in Arterial Thromboembolism Academic Article
-
Clinical Use of Low Molecular Weight Heparins and Heparinoids Academic Article
-
Clinical Validity of a Normal Perfusion Lung Scan in Patients with Suspected Pulmonary Embolism Academic Article
-
Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment Academic Article
-
Clinical factors influencing the sensitivity to warfarin when restarted after surgery Academic Article
-
Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry Academic Article
-
Clinical trials of deep vein thrombosis prophylaxis in medical patients Academic Article
-
Clinical trials of new anticoagulants. Academic Article
-
Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences Academic Article
-
Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why? Academic Article
-
Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease Academic Article
-
Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it? Academic Article
-
Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel” Academic Article
-
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
-
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor Academic Article
-
Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant Academic Article
-
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia Academic Article
-
Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis Academic Article
-
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation Academic Article
-
Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: A systematic review Academic Article
-
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) Academic Article
-
Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery” Academic Article
-
Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study Academic Article
-
Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery Academic Article
-
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism. Academic Article
-
Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Academic Article
-
Dabigatran and risk of myocardial infarction Academic Article
-
Dabigatran in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation Academic Article
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran versus warfarin in patients with mechanical heart valves: reply Academic Article
-
Dalteparin versus Unfractionated Heparin in Critically Ill Patients Academic Article
-
Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients Academic Article
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin Academic Article
-
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. Academic Article
-
Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study Academic Article
-
Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography Academic Article
-
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis Academic Article
-
Diagnostic Problems with Venous Thromboembolic Disease in Pregnancy Academic Article
-
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis Academic Article
-
Direct Factor Xa and direct thrombin inhibitors: a clinical trial update. Academic Article
-
Direct Oral Anticoagulants Academic Article
-
Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19 Academic Article
-
Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy? Academic Article
-
Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis Academic Article
-
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events Academic Article
-
Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement Academic Article
-
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer Academic Article
-
Drug-Induced Platelet Destruction Academic Article
-
Duration of anticoagulants in acute or recurrent venous thromboembolism Academic Article
-
EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE Academic Article
-
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial Academic Article
-
Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation Academic Article
-
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure Academic Article
-
Effect of suloctidil on platelet function in patients with shortened platelet. Survival time Academic Article
-
Effectiveness of Anticoagulants Academic Article
-
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial Academic Article
-
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients Academic Article
-
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Academic Article
-
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement Academic Article
-
Efficacy and safety of enoxaparin versus
unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment Academic Article
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Academic Article
-
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves Academic Article
-
Electrical Foot Stimulation and Implications for the Prevention of Venous Thromboembolic Disease Academic Article
-
Embolic strokes of undetermined source: support for a new clinical construct–Authors' reply Academic Article
-
Embolic strokes of undetermined source: the case for a new clinical construct Academic Article
-
Emerging anticoagulants for the treatment of venous thromboembolism Academic Article
-
Emerging themes in the treatment of venous thromboembolism Academic Article
-
Enhancing the informed consent process for critical care research: Strategies from a thromboprophylaxis trial Academic Article
-
Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery Academic Article
-
Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer Academic Article
-
Epidemiology and pathogenesis of venous thrombosis Academic Article
-
Epidemiology of Thrombosis in Cancer Academic Article
-
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression Conference Paper
-
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART Study Academic Article
-
Establishing a Therapeutic Range for Heparin Therapy Academic Article
-
Establishing an Optimal Therapeutic Range for Coumarins Academic Article
-
Evaluation of a Thromboprophylaxis Quality Improvement Project in a Palliative Care Unit Academic Article
-
Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis Academic Article
-
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism Academic Article
-
Extended Treatment of Venous Thromboembolism Academic Article
-
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy? Academic Article
-
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study Academic Article
-
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Academic Article
-
Factors at Admission Associated With Bleeding Risk in Medical Patients Academic Article
-
Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols Academic Article
-
Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Academic Article
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery Academic Article
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Academic Article
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison Academic Article
-
Fondaparinux versus enoxaparin for prevention of venous thromboembolism Academic Article
-
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle> Academic Article
-
Fondaparinux – evolution or revolution in anticoagulant care? Academic Article
-
Fondaparinux, the first selective factor Xa inhibitor Academic Article
-
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy Academic Article
-
From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer Academic Article
-
Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders. Academic Article
-
Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis Academic Article
-
Guide to Anticoagulant Therapy: Heparin Academic Article
-
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. Academic Article
-
Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Academic Article
-
Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis. Academic Article
-
Guidelines for the use of imaging techniques for the investigation of venous thromboembolic disease Academic Article
-
Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Academic Article
-
Hemorrhagic Complications of Anticoagulant Therapy Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism Academic Article
-
Hemorrhagic complications of long-term anticoagulant therapy. Academic Article
-
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Academic Article
-
Heparin Academic Article
-
Heparin Brand Is Associated With Postsurgical Outcomes in Children Undergoing Cardiac Surgery Academic Article
-
Heparin Therapy in Venous Thromboembolism Academic Article
-
Heparin and Angiogenesis Academic Article
-
Heparin and Graduated Compression Stockings in Patients Academic Article
-
Heparin induced bleeding. Academic Article
-
Heparin therapy during pregnancy. Risks to the fetus and mother Academic Article
-
Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns Academic Article
-
Heparin-induced thrombocytopenia: patient profiles and clinical manifestations. Academic Article
-
Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty. Academic Article
-
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
-
Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction? Academic Article
-
Homocysteine levels in pregnant women who smoke cigarettes Academic Article
-
Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism Academic Article
-
Hormone replacement therapy and risk for venous thromboembolism: what??s new and how do these findings influence clinical practice? Academic Article
-
How I treat anticoagulated patients undergoing an elective procedure or surgery Academic Article
-
Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. Academic Article
-
Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients Academic Article
-
Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis Academic Article
-
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the
XANTUS
real‐world prospective study Academic Article
-
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk Academic Article
-
Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review Academic Article
-
Incidence and Management of Thrombotic and Thromboembolic Complications Following the Superior Cavopulmonary Anastomosis Procedure: A Literature Review Academic Article
-
Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism Academic Article
-
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy Academic Article
-
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy Academic Article
-
Incident Atrial Fibrillation and Stroke in Patients With Atrial Flutter Academic Article
-
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries Academic Article
-
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments] Academic Article
-
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. Academic Article
-
Independent predictors of stroke in patients with atrial fibrillation: A systematic review Academic Article
-
Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism Academic Article
-
Influence of the duration of fondaparinux (Arixtra®) prophylaxis in preventing venous thromboembolism following major orthopedic surgery Academic Article
-
Inherited thrombophilia and pregnancy associated venous thromboembolism Academic Article
-
Inhibition of Injury Induced Thromboatherosclerotic Lesions by Anti-Platelet Serum in Rabbits Academic Article
-
Initial treatment of venous thromboembolism Academic Article
-
Integrating Frailty Assessment Into Cardiovascular Decision Making Academic Article
-
Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome Academic Article
-
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation Academic Article
-
International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement Academic Article
-
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis Academic Article
-
Interpretations. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks Academic Article
-
Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments Academic Article
-
Introduction Academic Article
-
Is the dose of warfarin prescribed by American physicians unnecessarily high? Academic Article
-
Knee replacement and HIT without heparin Academic Article
-
Larger A1/M1 Diameter Ratio Predicts Embolic Anterior Cerebral Artery Territorial Stroke Academic Article
-
Latest medical treatment strategies for venous thromboembolism Academic Article
-
Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis Academic Article
-
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia Academic Article
-
Lipoprotein(a): another risk factor for venous thrombosis? Academic Article
-
Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy? Academic Article
-
Looking forward in the treatment of deep-vein thrombosis Academic Article
-
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
-
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin Academic Article
-
Low-Molecular-Weight Heparin in Pediatric Patients Academic Article
-
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Academic Article
-
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Academic Article
-
Low-Molecular-Weight Heparins Academic Article
-
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery Academic Article
-
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants Academic Article
-
Low-molecular-weight heparin for the treatment of venous thromboembolism. Academic Article
-
Low-molecular-weight heparin: from the bench to the orthopedic patient. Academic Article
-
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis Academic Article
-
Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Academic Article
-
Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction Academic Article
-
Management of Anticoagulation before and after Elective Surgery Academic Article
-
Management of Bleeding in Patients Receiving Conventional or New Anticoagulants Academic Article
-
Management of Venous Thromboembolism: Present and Future Academic Article
-
Management of bleeding with oral anticoagulants in patients with atrial fibrillation Academic Article
-
Management of heterotopic ossification and venous thromboembolism following acquired brain injury Academic Article
-
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study Academic Article
-
Management of thromboembolic disease in cancer patients. Academic Article
-
Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey Academic Article
-
Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents Academic Article
-
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer Academic Article
-
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy Academic Article
-
Mechanical valves Academic Article
-
Mechanism of Action and Monitoring of Anticoagulants Academic Article
-
Mechanism of Action and Pharmacology of Unfractionated Heparin Academic Article
-
Meta-Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study Academic Article
-
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
-
Monitoring the anticoagulant effect after a massive rivaroxaban overdose Academic Article
-
Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups Academic Article
-
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials Academic Article
-
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada Academic Article
-
Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism Academic Article
-
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation Academic Article
-
New Anticoagulant Drugs Academic Article
-
New Anticoagulants Academic Article
-
New Anticoagulants Academic Article
-
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
New Frontiers in the Management of Unstable Coronary Artery Disease Academic Article
-
New anticoagulants Academic Article
-
New anticoagulants Conference Paper
-
New antithrombotic agents—insights from clinical trials Academic Article
-
New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism Academic Article
-
New oral anticoagulants in atrial fibrillation Academic Article
-
New oral anticoagulants in development Academic Article
-
New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction? Academic Article
-
Newly Diagnosed Malignancy in Patients with VenousThromboembolism. Search or Wait and See? Academic Article
-
Non-biological factors in day to day variation of heparin requirements. Academic Article
-
Non-traumatic vascular emergencies: imaging and intervention in acute arterial conditions Academic Article
-
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel Academic Article
-
Novel Oral Anticoagulants for Atrial Fibrillation Academic Article
-
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
On the need for a workshop on venous thromboembolism in critical care Academic Article
-
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits Academic Article
-
Opinions in pediatric and adolescent gynecology Academic Article
-
Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism Academic Article
-
Optimal therapeutic range for oral anticoagulants. Academic Article
-
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding Academic Article
-
Optimizing Prophylaxis of Venous Thromboembolism Academic Article
-
Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer Academic Article
-
Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data Academic Article
-
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin Academic Article
-
Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF Academic Article
-
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Academic Article
-
Oral anticoagulation for prolonging survival in patients with cancer Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings Academic Article
-
Oral contraceptive use is a provoking factor for venous thromboembolism Academic Article
-
Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases Academic Article
-
Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry Academic Article
-
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Overview of the clinical results of pentasaccharide in major orthopedic surgery. Academic Article
-
PREVENTION OF VENOUS THROMBO‐EMBOLISM Academic Article
-
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation Academic Article
-
Patient outcomes using the European label for dabigatran Academic Article
-
Pediatric edition thrombosis research Academic Article
-
Pentasaccharides Academic Article
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
-
Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery Academic Article
-
Perioperative Management of Dabigatran Academic Article
-
Perioperative Management of Oral Anticoagulation Academic Article
-
Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach Academic Article
-
Perioperative Management of Patients Receiving Oral Anticoagulants Academic Article
-
Perioperative Management of Patients Receiving Oral Anticoagulants Academic Article
-
Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question Academic Article
-
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide Academic Article
-
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians Academic Article
-
Perioperative anticoagulation—are we at 'a bridge too far'? Academic Article
-
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Academic Article
-
Perioperative management of antithrombotic therapy Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach Academic Article
-
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
-
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Academic Article
-
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants Academic Article
-
Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery Academic Article
-
Pharmacology of the low-molecular-weight heparins Academic Article
-
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial Academic Article
-
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer Academic Article
-
Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery Academic Article
-
Plasma fibrinopeptide A levels in symptomatic venous thromboembolism Academic Article
-
Platelet Consumption in Cardiovascular Disease Academic Article
-
Platelet inhibitors in the treatment of thrombosis. Academic Article
-
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects Academic Article
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
-
Platelets. Academic Article
-
Portal vein thrombosis causing neonatal cerebral infarction Academic Article
-
Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem Academic Article
-
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial Academic Article
-
Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months Academic Article
-
Pregnancy, Heparin and Osteoporosis Academic Article
-
Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients Academic Article
-
Preventing Thromboembolism in Patients with Prosthetic Heart Valves Academic Article
-
Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Academic Article
-
Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement Academic Article
-
Prevention of Venous Thromboembolism Academic Article
-
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients Academic Article
-
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation Academic Article
-
Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents Academic Article
-
Prevention of venous thromboembolism after surgery: A review of enoxaparin Academic Article
-
Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study Academic Article
-
Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study Academic Article
-
Prevention of venous thromboembolism in medical patients with enoxaparin Academic Article
-
Prevention of venous thromboembolism in medically ill patients: a clinical update Academic Article
-
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Academic Article
-
Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE). Academic Article
-
Procoagulants for management of bleeding with the new oral anticoagulants Academic Article
-
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran Academic Article
-
Prophylaxis and Therapy of Venous Thromboembolism Academic Article
-
Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene Academic Article
-
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study Academic Article
-
Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study Academic Article
-
Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease Academic Article
-
Präoperative Bewertung des Blutungs- und Thromboseembolierisikos Academic Article
-
Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group. Academic Article
-
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome Academic Article
-
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism Academic Article
-
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
-
Rates and determinants of informed consent: A case study of an international thromboprophylaxis trial Academic Article
-
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention Academic Article
-
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial Academic Article
-
Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034 Academic Article
-
Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702. Academic Article
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 Academic Article
-
Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins Academic Article
-
Recommendations on biosimilar low‐molecular‐weight heparins Academic Article
-
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial Academic Article
-
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach Academic Article
-
Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure Academic Article
-
Relationship Between Thromboembolic Complications and Intensity of Treatment During Long-Term Prophylaxis with Oral Anticoagulants Following DVT Academic Article
-
Reply to Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism Academic Article
-
Reproductive Issues in Patients With the Fontan Operation Academic Article
-
Research ethics board approval for an international thromboprophylaxis trial Academic Article
-
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study Academic Article
-
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Academic Article
-
Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban” Academic Article
-
Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children Academic Article
-
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply Academic Article
-
Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin Academic Article
-
Reversal of novel oral anticoagulants in patients with major bleeding Academic Article
-
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism Academic Article
-
Risk Assessment and Primary VTE Prevention in the Cancer Patient Academic Article
-
Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness Academic Article
-
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism Academic Article
-
Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia Academic Article
-
Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding Academic Article
-
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism Academic Article
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry Academic Article
-
Risks and Benefits of Anticoagulant Therapy Academic Article
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
-
Risks to the Fetus of Anticoagulant Therapy During Pregnancy Academic Article
-
Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease Academic Article
-
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice Academic Article
-
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
-
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism Academic Article
-
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE) Academic Article
-
Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention Academic Article
-
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism Academic Article
-
Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Academic Article
-
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists Academic Article
-
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk Academic Article
-
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation Academic Article
-
Searching for Atrial Fibrillation Poststroke Academic Article
-
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Academic Article
-
Setting a standard for venous thromboembolism prophylaxis Academic Article
-
Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement Academic Article
-
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin Academic Article
-
Spontaneous neonatal arterial thromboembolism Academic Article
-
Starting prophylaxis for venous thromboembolism postoperatively Academic Article
-
State of the Art-A Journey through the World of Antithrombotic Therapy Academic Article
-
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update Academic Article
-
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial Academic Article
-
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Academic Article
-
Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification? Academic Article
-
Stroke and Thromboprophylaxis in the Era of COVID-19 Academic Article
-
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial Academic Article
-
Successors to heparin: new antithrombotic agents. Academic Article
-
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology Academic Article
-
Systemic thromboembolism in children Academic Article
-
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE Academic Article
-
The Activated Partial Thromboplastin Time in the Control of Heparin Treatment Academic Article
-
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Academic Article
-
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results. Academic Article
-
The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty Academic Article
-
The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis Academic Article
-
The Diagnosis and Management of Ovarian Hyperstimulation Syndrome Academic Article
-
The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial Academic Article
-
The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus Academic Article
-
The Effects of Needleless Connectors on Catheter-Related Thrombotic Occlusions Academic Article
-
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle> Conference Paper
-
The Pharmacology and Management of the Vitamin K Antagonists Academic Article
-
The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study Academic Article
-
The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan Academic Article
-
The Role of Ximelagatran in the Treatment of Venous Thromboembolism Academic Article
-
The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery Academic Article
-
The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia Academic Article
-
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Academic Article
-
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Academic Article
-
The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial Academic Article
-
The epidemiology of venous thromboembolism Academic Article
-
The hazards of interrupting anticoagulation therapy in atrial fibrillation Academic Article
-
The hypercoagulable state in cancer patients Academic Article
-
The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism Academic Article
-
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
-
The reemergence of aspirin for the prevention of venous thromboembolism. Academic Article
-
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin Academic Article
-
The role of surgeon volume on patient outcome in total knee arthroplasty: a systematic review of the literature Academic Article
-
The safety of fondaparinux for the prevention and treatment of venous thromboembolism Academic Article
-
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group. Academic Article
-
The status of new anticoagulants Academic Article
-
The treatment of venous thromboembolism. Academic Article
-
The use of low molecular weight heparin in pediatric patients: A prospective cohort study Academic Article
-
The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease. Academic Article
-
The worcester venous thromboembolism study Academic Article
-
Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin Academic Article
-
Thromboembolic Complications in Pediatric Hematologic Malignancies Academic Article
-
Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study Conference Paper
-
Thromboembolic Disease and Antithrombotic Therapy in Newborns Academic Article
-
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants Academic Article
-
Thromboembolic complications in children with cancer Academic Article
-
Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management Academic Article
-
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials Academic Article
-
Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy Academic Article
-
Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding Academic Article
-
Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators. Academic Article
-
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Academic Article
-
Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study Academic Article
-
Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management Academic Article
-
Thromboembolism and pregnancy. Academic Article
-
Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long-Term Parenteral Nutrition Academic Article
-
Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease Academic Article
-
Thromboembolism in children with lymphoma Academic Article
-
Thromboembolism in children with sarcoma Academic Article
-
Thromboepidemiology: Identifying patients with heritable risk for thrombin-mediated thromboembolic events Academic Article
-
Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin Academic Article
-
Thrombophilia and New Anticoagulant Drugs Academic Article
-
Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis Academic Article
-
Thromboprophylaxis in Medical Patients – Why Not For All? Conference Paper
-
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin Academic Article
-
Thromboprophylaxis in surgical patients. Academic Article
-
Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia Academic Article
-
Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Academic Article
-
Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Academic Article
-
Thrombosis and Thromboembolic Complications in Fontan Patients Academic Article
-
Thrombosis in children with acute lymphoblastic leukemia Academic Article
-
Thrombosis in children with acute lymphoblastic leukemia Academic Article
-
Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from
CYP‐C Academic Article
-
Thrombotic Complications of Neonates and Children with Congenital Nephrotic Syndrome Academic Article
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia Academic Article
-
Treatment and prophylaxis of venous thromboembolism during pregnancy Academic Article
-
Treatment of First Episode of Venous Thrombosis Academic Article
-
Treatment of Venous Thromboembolism in Cancer Patients Academic Article
-
Treatment of Venous Thromboembolism in Patients with Congenital Deficiency of Antithrombin III Academic Article
-
Treatment of Venous Thrombosis in the Cancer Patient Academic Article
-
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Academic Article
-
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial Academic Article
-
Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users Academic Article
-
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial Academic Article
-
Use of Antithrombotic Agents During Pregnancy Academic Article
-
Use of anticoagulants during pregnancy. Academic Article
-
Use of antithrombotic agents during pregnancy. Academic Article
-
Use of different d‐dimer levels to exclude venous thromboembolism depending on clinical pretest probability Academic Article
-
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Academic Article
-
Use of selective factor Xa inhibitors in special populations. Academic Article
-
VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY Academic Article
-
Venous Thromboembolic Disease Academic Article
-
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients Academic Article
-
Venous Thromboembolism and Cancer Academic Article
-
Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients Academic Article
-
Venous thromboembolism and its prevention in critical care Academic Article
-
Venous thromboembolism in patients undergoing rehabilitation for stroke. Academic Article
-
Venous thromboembolism in travellers: can we identify those at risk? Academic Article
-
Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review Academic Article
-
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux. Academic Article
-
Venous thromboembolism: diagnosis and management of deep venous thrombosis Academic Article
-
Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation. Academic Article
-
Warfarin After Bioprosthetic Aortic Valve Implantation Academic Article
-
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios Academic Article
-
When and how to use heparin prophylaxis and treatment. Academic Article
-
Ximelagatran for Secondary Prevention of Venous Thromboembolism Academic Article
-
Ximelagatran for the secondary prevention of venous thromboembolism. A complementary follow-up analysis of the THRIVE III Study Academic Article
-
Ximelagatran or warfarin in atrial fibrillation? Academic Article
-
Ximelagatran: the first oral direct thrombin inhibitor. Academic Article
-
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. Academic Article
-
[There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis]. Academic Article